Richard Shannon

Ross Cole

Tim Savageaux

Tyler Anderson

Charles Shi

Danny Cheng

Dave Kang

Matthew Bryson

Timothy Savageaux

- AXTI reported **Q3 2025 revenue of $28.0 million**, marking a **56% sequential increase** and **18% year-over-year growth**, primarily driven by a significant uptick in **Indium Phosphide demand** from data center applications.  **[0001051627_2218239_1]** **[0001051627_2218239_3]** 
- The company's non-GAAP gross margin improved to **22.4%**, and it reported a non-GAAP net loss of **$1.2 million**, or **$0.03 per share**, showing substantial improvement compared to the prior quarter.  **[0001051627_2218239_1]** 
- The Indium Phosphide order backlog has grown to **over $49 million**, which is the largest in the company's history, fueled by the AI infrastructure buildout and new Tier 1 customer engagements.  **[0001051627_2218239_3]** **[0001051627_2218239_5]** 
- For **Q4 2025**, AXTI provided revenue guidance in the range of **$27 million to $30 million** and a non-GAAP net loss guidance of **$0.01 to $0.03 per share**, with the timing of export permits identified as the most significant factor for growth.  **[0001051627_2218239_5]** 
- The company currently has Indium Phosphide capacity of approximately **$20 million per quarter** and can increase it by 25% within three months or double it in about nine months with an estimated **$10 million to $15 million** in capital expenditure.  **[0001051627_2218239_10]**

AXTI Reports Strong Q3 2025 Revenue Growth and Increased Indium Phosphide Backlog

- **AXT, Inc. reported Q3 2025 revenue of $28.0 million**, a significant increase from **$18.0 million in Q2 2025** and **$23.6 million in Q3 2024**.  **[1051627_ca294545753f42c4abf0a9e72dd8f125_0]** 
- The company's **GAAP net loss improved to $1.9 million, or $0.04 per share**, in Q3 2025, compared to a **net loss of $7.0 million, or $0.16 per share**, in Q2 2025.  **[1051627_ca294545753f42c4abf0a9e72dd8f125_0]** 
- **GAAP gross margin increased to 22.3 percent** of revenue for Q3 2025, up from **8.0 percent in Q2 2025**.  **[1051627_ca294545753f42c4abf0a9e72dd8f125_0]** 
- CEO Morris Young highlighted a **strong sequential growth of over 250 percent in indium phosphide revenues** due to data center demand, reaching a three-year high, and expressed belief in **meaningful growth and a return to profitability in 2026**.  **[1051627_ca294545753f42c4abf0a9e72dd8f125_0]** 
- The **STAR Market IPO application for its subsidiary, Tongmei, is awaiting review and approval** by the CSRC and other authorities, with the company hoping to complete it in the coming months.  **[1051627_ca294545753f42c4abf0a9e72dd8f125_1]**

AXT, Inc. Announces Third Quarter 2025 Financial Results

- AXT, Inc. reported **revenue of $28.0 million** for the third quarter of 2025, a substantial increase from $18.0 million in the second quarter of 2025.  **[1051627_0001437749-25-032429_ex_854006.htm:0]** 
- The company's GAAP net loss for Q3 2025 improved to **$1.9 million, or $0.04 per share**, compared to a net loss of $7.0 million, or $0.16 per share, in the previous quarter.  **[1051627_0001437749-25-032429_ex_854006.htm:0]** 
- Indium phosphide revenues **grew over 250 percent sequentially** in Q3 2025, reaching a three-year high, driven by strong demand from data center applications and the securing of export permits.  **[1051627_0001437749-25-032429_ex_854006.htm:0]** 
- Management anticipates **meaningful growth and a return to profitability in 2026**, fueled by strong market trends in the data center upgrade cycle.  **[1051627_0001437749-25-032429_ex_854006.htm:0]** 
- The initial public offering application for its subsidiary, Tongmei, on the Shanghai Stock Exchange's STAR Market remains **under review by the CSRC** and other authorities, with completion hoped for in the coming months.  **[1051627_0001437749-25-032429_ex_854006.htm:1]**

AXT (AXTI)